Literature DB >> 9445115

Technetium-99m-labeled white blood cells: a new method to define the local and systemic role of leukocytes in acute experimental pancreatitis.

J Werner1, S C Dragotakes, C Fernandez-del Castillo, J A Rivera, J Ou, D W Rattner, A J Fischman, A L Warshaw.   

Abstract

OBJECTIVE: We developed a new method to quantitate leukocyte accumulation in tissues and used it to examine the time course and severity of acute experimental pancreatitis.
BACKGROUND: Leukocyte activation and infiltration are believed to be critical steps in the progression from mild to severe pancreatitis and responsible for many of its systemic complications.
METHODS: Pancreatitis of graded severity was induced in Sprague-Dawley rats with a combination of caerulein and controlled intraductal infusion. Technetium-99m (99mTc)-labeled leukocytes were quantified in pancreas, lung, liver, spleen, and kidney and compared with myeloperoxidase activity. The severity of pancreatitis was ascertained by wet/dry weight ratio, plasma amylase, and trypsinogen activation peptide in the pancreas. The time course of leukocyte accumulation was determined over 24 hours.
RESULTS: Pancreatic leukocyte infiltration correlated well with tissue myeloperoxidase concentrations. In mild pancreatitis, leukocytes accumulated only in the pancreas. Moderate and severe pancreatitis were characterized by much greater leukocyte infiltration in the pancreas than in mild disease (p < 0.01), and increased 99mTc radioactivity was detectable in the lung as early as 3 hours. 99mTc radioactivity correlated directly with the three levels of pancreatitis.
CONCLUSIONS: Mild pancreatitis is characterized by low-level leukocyte activation and accumulation in the pancreas without recruitment of other organs; marked leukocyte accumulation was found in the pancreas and in the lung in more severe grades of pancreatitis. These findings provide a basis for the pathophysiologic production of cytokines and oxygen free radicals, which potentiate organ injury in severe pancreatitis. This study validates a new tool to study local and systemic effects of leukocytes in pancreatitis as well as new therapeutic hypotheses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445115      PMCID: PMC1191177          DOI: 10.1097/00000658-199801000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  45 in total

1.  A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions.

Authors:  M Ceska; K Birath; B Brown
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

2.  An impaired phagocytic function is associated with leucocyte activation in the early stages of severe acute pancreatitis.

Authors:  G Liras; F Carballo
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

3.  The interaction of leukocytes and erythrocytes in capillary and postcapillary vessels.

Authors:  G W Schmid-Schönbein; S Usami; R Skalak; S Chien
Journal:  Microvasc Res       Date:  1980-01       Impact factor: 3.514

4.  Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis.

Authors:  A C de Beaux; J A Ross; J P Maingay; K C Fearon; D C Carter
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

5.  Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression.

Authors:  B C Marcus; C W Wyble; K L Hynes; B L Gewertz
Journal:  Surgery       Date:  1996-08       Impact factor: 3.982

6.  Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis.

Authors:  J Werner; J Rivera; C Fernandez-del Castillo; K Lewandrowski; C Adrie; D W Rattner; A L Warshaw
Journal:  Surgery       Date:  1997-01       Impact factor: 3.982

7.  Heparin in clinical doses 'primes' granulocytes to subsequent activation as measured by myeloperoxidase release.

Authors:  V Videm
Journal:  Scand J Immunol       Date:  1996-04       Impact factor: 3.487

8.  Active interleukin-1 receptor required for maximal progression of acute pancreatitis.

Authors:  J G Norman; G Fink; M Franz; J Guffey; G Carter; B Davison; C Sexton; M Glaccum
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

9.  Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis.

Authors:  A M Gudgeon; D I Heath; P Hurley; A Jehanli; G Patel; C Wilson; A Shenkin; B M Austen; C W Imrie; J Hermon-Taylor
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

10.  Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. II. Cytochemistry and electron microscopy of bone marrow cells.

Authors:  D F Bainton; M G Farquhar
Journal:  J Cell Biol       Date:  1968-11       Impact factor: 10.539

View more
  10 in total

1.  Efficacy of glucocorticoids in rodents of severe acute pancreatitis: a meta-analysis.

Authors:  Min Yu; Zhen Yang; Yin Zhu; Nonghua Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Expression and significance of ICAM-1 and its counter receptors LFA-1 and Mac-1 in experimental acute pancreatitis of rats.

Authors:  Wei Sun; Yasuhiro Watanabe; Zhong-Qiu Wang
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

3.  Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1.

Authors:  J Werner; K Z'graggen; C Fernández-del Castillo; K B Lewandrowski; C C Compton; A L Warshaw
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

4.  Glutathione depletion with L-buthionine-(S,R)-sulfoximine demonstrates deleterious effects in acute pancreatitis of the rat.

Authors:  G Alsfasser; M Gock; L Herzog; M M Gebhard; C Herfarth; E Klar; J Schmidt
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

5.  Effects of mast-cell stabilization in cerulein-induced acute pancreatitis in rats.

Authors:  N Yönetçi; N Oruç; A O Ozütemiz; H A Celik; G Yüce
Journal:  Int J Pancreatol       Date:  2001

6.  Netrin-1 protects against L-Arginine-induced acute pancreatitis in mice.

Authors:  Ji Chen; Qing-Ping Cai; Pi-Jie Shen; Rong-Lin Yan; Chang-Ming Wang; De-Jun Yang; Hong-Bing Fu; Xue-Yun Chen
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal.

Authors:  Argyris Tzouvelekis; George Koliakos; Paschalis Ntolios; Irene Baira; Evangelos Bouros; Anastasia Oikonomou; Athanassios Zissimopoulos; George Kolios; Despoina Kakagia; Vassilis Paspaliaris; Ioannis Kotsianidis; Marios Froudarakis; Demosthenes Bouros
Journal:  J Transl Med       Date:  2011-10-21       Impact factor: 5.531

8.  A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

Authors:  Argyris Tzouvelekis; Vassilis Paspaliaris; George Koliakos; Paschalis Ntolios; Evangelos Bouros; Anastasia Oikonomou; Athanassios Zissimopoulos; Nikolaos Boussios; Brian Dardzinski; Dimitrios Gritzalis; Antonis Antoniadis; Marios Froudarakis; George Kolios; Demosthenes Bouros
Journal:  J Transl Med       Date:  2013-07-15       Impact factor: 5.531

9.  Effects of thoracic epidural anesthesia on survival and microcirculation in severe acute pancreatitis: a randomized experimental trial.

Authors:  Kai A Bachmann; Constantin J C Trepte; Lena Tomkötter; Andrea Hinsch; Jan Stork; Wilken Bergmann; Lena Heidelmann; Tim Strate; Alwin E Goetz; Daniel A Reuter; Jakob R Izbicki; Oliver Mann
Journal:  Crit Care       Date:  2013-12-05       Impact factor: 9.097

10.  Drug discovery and formulation development for acute pancreatitis.

Authors:  Xue Jiang; Ya-Wen Zheng; Shihui Bao; Hailin Zhang; Ruijie Chen; Qing Yao; Longfa Kou
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.